EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

A population‐based time‐series analysis of opioid agonist treatment dispensed during pregnancy

Rose A Schmidt iD, Karl Everett, Amaya Perez-Brumer, Carol Strike, Brian Rush, Tara Gomes iD

Addiction · 2024

DOI: 10.1111/add.16459 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Addiction, 2024. Verfasst von Rose A Schmidt und 5 weiteren Autor:innen. Beteiligte Einrichtung: Dalla Lana School of Public Health, University of Toronto, Toronto, Canada. Hauptthemen laut MEDLINE: Methadone, Opioid-Related Disorders, Opiate Substitution Treatment, Pregnancy Complications. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ontario Health Data Platform, Institute for Clinical Evaluative Sciences, Ministry of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and aims Identifying effective opioid treatment options during pregnancy is a high priority due to the growing prevalence of opioid use disorder across North America. We assessed the temporal impact of three population‐level interventions on the use of opioid agonist treatment (OAT) during pregnancy in Ontario, Canada.

Design

This was a population‐based time‐series analysis to identify trends in the monthly prevalence of pregnant people dispensed methadone and buprenorphine. The impact of adding buprenorphine/naloxone to the public drug formulary, the release of pregnancy‐specific guidance and the start of the COVID‐19 pandemic were assessed. Setting and participants The study was conducted in Ontario, Canada between 1 July 2013 and 31 March 2022, comprising people who delivered a live or stillbirth in any Ontario hospital during the study period.

Measurements

We identified any prescription for methadone or buprenorphine dispensed between the estimated conception date and delivery date and calculated the monthly prevalence of OAT‐exposed pregnancies among all pregnant people in Ontario.

Findings

Overall, rates of OAT during pregnancy have declined since mid‐2018. Methadone‐exposed pregnancies decreased from 0.46% of all pregnancies in Ontario in 2015 to a low of 0.16% in 2022. In the primary analysis, none of the interventions had a statistically significant impact on overall OAT rates; however, in the stratified analyses, there was a small increase in buprenorphine after the formulary change [0.006%, 95% confidence interval (CI) = 0.0032−0.0081, P < 0.0001] and a decrease in buprenorphine after the release of the 2017 guidelines (−0.005%, 95% CI = −0.0080 to −0.0020, P = 0.001) and the start of the COVID‐19 pandemic (−0.003%, 95% CI = −0.0054 to −0.0006, P = 0.015).

Conclusion

Despite changes in guidance and funding, opioid agonist treatment during pregnancy has been declining in Ontario, Canada since 2018.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MethadoneOpioid-Related DisordersOpiate Substitution TreatmentPregnancy ComplicationsCOVID-19HumansFemalePregnancyOntarioAdultBuprenorphineAnalgesics, OpioidBuprenorphine, Naloxone Drug CombinationNarcotic Antagonists

Stichwörter der Autor:innen

Buprenorphineecological studymedications for opioid use disordermethadoneopioid agonist treatmentopioidspregnancytime‐series analysis

Substanzen

MethadoneBuprenorphineAnalgesics, OpioidBuprenorphine, Naloxone Drug CombinationNarcotic Antagonists

Autor:innen und Institutionen

  • Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.
  • Centre for Addiction and Mental Health (CAMH), Institute for Mental Health Policy Research, Toronto, Canada.
  • ICES, Toronto, Canada.
  • Li Ka Shing Knowledge Institute of St Michael's Hospital, Toronto, Canada.
  • Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada.
  • Management and Evaluation at the University of Toronto, Institute of Health Policy, Toronto, Ontario, Canada.

ORCID-Profile: Rose A Schmidt, Tara Gomes

Förderung

  • Ontario Health Data Platform
  • Institute for Clinical Evaluative Sciences
  • Ministry of Health
  • Ontario Ministry of Health and Long-Term Care
  • Ministry of Health, British Columbia

Zitieren

APA

Schmidt, R. A., Everett, K., Perez-Brumer, A., Strike, C., Rush, B., & Gomes, T. (2024). A population‐based time‐series analysis of opioid agonist treatment dispensed during pregnancy. Addiction. https://doi.org/10.1111/add.16459

Vancouver

Schmidt RA, Everett K, Perez-Brumer A, Strike C, Rush B, Gomes T. A population‐based time‐series analysis of opioid agonist treatment dispensed during pregnancy. Addiction. 2024. doi:10.1111/add.16459

BibTeX
@article{Schmidt2024,
  author = {Schmidt, Rose A and Everett, Karl and Perez-Brumer, Amaya and Strike, Carol and Rush, Brian and Gomes, Tara},
  title = {A population‐based time‐series analysis of opioid agonist treatment dispensed during pregnancy},
  journal = {Addiction},
  year = {2024},
  doi = {10.1111/add.16459}
}
Kostenlos starten →